The BSE Sensex closed 249.90 points down at 35,884.41 and the Nifty 50 ended 84.55 points lower at 10,784.95. Here are the highlights from the markets

Indian benchmark indices BSE Sensex and NSE’s Nifty 50 declined on Wednesday following a selloff in global equities amid concerns over US-China trade
negotiations and global economic growth. Investors are cautious ahead of the Reserve Bank of India’s monetary policy decision today after 2.30pm. According to a Mint survey, RBI will keep the repo rate unchanged at 6.5%, while it will maintain the policy stance at “calibrated tightening”. Asian stocks fell following losses on Wall Street overnight after US threatened more tariffs, though US futures rose after Beijing officially said it was ready to implement trade terms agreed with US.  Oil prices fell 1%, weighed down by rising US inventories and a plunge in global stock markets.

3.35 pm IST
Closing bell: Sensex, Nifty fall for 2nd session
The BSE Sensex closed 249.90 points, or 0.69%, down at 35,884.41 and the Nifty 50 ended 84.55 points, or 0.74%, lower at 10,784.95.

3.02 pm IST
Sensex, Nifty extend losses
The BSE Sensex traded 297.48 points, or 0.82%, down at 35,836.83, and the Nifty 50 fell 99.65 points, or 0.92%, to 10,739.85.

2.10 pm IST
USFDA issues observations at Lupin’s Mandideep location Lupin said the USFDA has concluded inspections at its Mandideep location, which
houses the company’s cardiovascular “Pril” API facilities, Cephalosporin API facilities and Cephalosporin solid oral dosage form facility. These inspections
were carried out between November 26 and December 4, 2018.  The US regulator has issued 4 observations for Unit-2, the Cardiovascular “Pri l”
API facilities; 10 observations for Unit-I, the Cephalosporin facilities; and 8 observations for the Cephalosporin Solid oral dosage form facility.
“The observations are largely procedural in nature with some gaps identified in the aseptic processing areas of the Cepha losporin API block and the company is confident of addressing them satisfactorily,” said Lupin.  Lupin shares traded 2.48% down at Rs 866.05 per share.

source: livemint.com